Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1981 May;43(5):701–735. doi: 10.1038/bjc.1981.102

Transition from laboratory to clinic in cancer treatment. Abstracts of symposium papers.

PMCID: PMC2010689  PMID: 7248155

Full text

PDF
701

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams G. E., O'Neill P., Ahmed I., Stratford I. J., Fielden E. M. The development of some nitroimidazoles as hypoxic cell sensitizers. Cancer Clin Trials. 1980 Spring;3(1):37–42. [PubMed] [Google Scholar]
  2. Ash D. V., Smith M. R., Bugden R. D. Distribution of misonidazole in human tumours and normal tissues. Br J Cancer. 1979 May;39(5):503–509. doi: 10.1038/bjc.1979.93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bitran J. D., Desser R. K., Kozloff M. F., Billings A. A., Shapiro C. M. Treatment of metastatic pancreatic and gastric adenocarcinomas with 5-fluorouracil, adriamycin, and mitomycin C (FAM). Cancer Treat Rep. 1979 Nov-Dec;63(11-12):2049–2051. [PubMed] [Google Scholar]
  4. Borel J. F., Feurer C., Gubler H. U., Stähelin H. Biological effects of cyclosporin A: a new antilymphocytic agent. Agents Actions. 1976 Jul;6(4):468–475. doi: 10.1007/BF01973261. [DOI] [PubMed] [Google Scholar]
  5. Brecher G., Smith W. W., Wilson S., Fred S. Kinetics of colchicine-induced hemopoietic recovery in irradiated mice. Radiat Res. 1967 Mar;30(3):600–610. [PubMed] [Google Scholar]
  6. CLAIN A., HUNT A. H. Adrenalectomy for intracranial metastases from carcinoma of the breast. Br Med J. 1956 Sep 15;2(4993):627–629. doi: 10.1136/bmj.2.4993.627. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fowler J. F., Denekamp J. A review of hypoxic cell radiosensitization in experimental tumors. Pharmacol Ther. 1979;7(3):413–444. doi: 10.1016/0163-7258(79)90039-1. [DOI] [PubMed] [Google Scholar]
  8. Gresser I., Tovey M. G. Antitumor effects of interferon. Biochim Biophys Acta. 1978 Oct 27;516(2):231–247. doi: 10.1016/0304-419x(78)90009-4. [DOI] [PubMed] [Google Scholar]
  9. Harrap K. R., Riches P. G., Gilby E. D., Sellwood S. M., Wilkinson R., Konyves I. Studies on the toxicity and antitumour activity of prednimustine, a prednisolone ester of chlorambucil. Eur J Cancer. 1977 Aug;13(8):873–881. doi: 10.1016/0014-2964(77)90143-8. [DOI] [PubMed] [Google Scholar]
  10. Harrap K. R., Taylor G. A., Browman G. P. Enhancement of the therapeutic effectiveness of methotrexate and protection of normal proliferating tissues with purines and pyrimidines. Chem Biol Interact. 1977 Jul;18(1):119–128. doi: 10.1016/0009-2797(77)90147-8. [DOI] [PubMed] [Google Scholar]
  11. Harrap K. R. Towards selectivity in cancer chemotherapy: a biochemical overview. Adv Enzyme Regul. 1978;17:457–478. doi: 10.1016/0065-2571(79)90027-x. [DOI] [PubMed] [Google Scholar]
  12. Jeney A., Jr, Connors T. A., Jones M. The toxicity of merophan after pretreatment with subtoxic dose. Acta Physiol Acad Sci Hung. 1968;33(1):89–94. [PubMed] [Google Scholar]
  13. MacDonald J. S., Woolley P. V., Smythe T., Ueno W., Hoth D., Schein P. S. 5-fluorouracil, adriamycin, and mitomycin-C (FAM) combination chemotherapy in the treatment of advanced gastric cancer. Cancer. 1979 Jul;44(1):42–47. doi: 10.1002/1097-0142(197907)44:1<42::aid-cncr2820440108>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  14. McElwain T. J., Toy J., Smith E., Peckham M. J., Austin D. E. A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's disease. Br J Cancer. 1977 Aug;36(2):276–280. doi: 10.1038/bjc.1977.187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Millar J. L., Blackett N. M., Hudspith B. N. Enhanced post-irradiation recovery of the haemopoietic system in animals pretreated with a variety of cytotoxic agents. Cell Tissue Kinet. 1978 Sep;11(5):543–553. doi: 10.1111/j.1365-2184.1978.tb00826.x. [DOI] [PubMed] [Google Scholar]
  16. Millar J. L., Clutterbuck R. D., Smith I. E. Improving the therapeutic index of two alkylating agents. Br J Cancer. 1980 Sep;42(3):485–487. doi: 10.1038/bjc.1980.263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Millar J. L., McElwain T. J. Combinations of cytotoxic agents that have less than expected toxicity on normal tissues in mice. Antibiot Chemother (1971) 1978;23:271–282. doi: 10.1159/000401490. [DOI] [PubMed] [Google Scholar]
  18. Millar J. L., Phelps T. A., Carter R. L., McElwain T. J. Cyclophosphamide pretreatment reduces the toxic effect of high dose melphalan on intestinal epithelium in sheep. Eur J Cancer. 1978 Nov;14(11):1283–1285. doi: 10.1016/0014-2964(78)90236-0. [DOI] [PubMed] [Google Scholar]
  19. Millar S. Effects of tactual and phonological similarity on the recall of Braille letters by blind children. Br J Psychol. 1975 May;66(2):193–201. doi: 10.1111/j.2044-8295.1975.tb01455.x. [DOI] [PubMed] [Google Scholar]
  20. Moertel C. G. Chemotherapy of gastrointestinal cancer. Clin Gastroenterol. 1976 Sep;5(3):777–793. [PubMed] [Google Scholar]
  21. Phelps T. A., Blackett N. M. Protection of intestinal damage by pretreatment with cytarabine (cytosine arabinoside). Int J Radiat Oncol Biol Phys. 1979 Sep;5(9):1617–1620. doi: 10.1016/0360-3016(79)90784-3. [DOI] [PubMed] [Google Scholar]
  22. Riches P. G., Harrap K. R. Some effects of chlorambucil on the chromatin of Yoshida ascites sarcoma cells. Cancer Res. 1973 Feb;33(2):389–393. [PubMed] [Google Scholar]
  23. Riches P. G., Sellwood S. M., Harrap K. R. Some effects of chlorambucil on nuclear protein phosphorylation in the Yoshida ascites sarcoma. Chem Biol Interact. 1977 Jul;18(1):11–22. doi: 10.1016/0009-2797(77)90137-5. [DOI] [PubMed] [Google Scholar]
  24. Smith W. W., Wilson S. M., Fred S. S. Kinetics of stem cell depletion and proliferation: effects of vinblastine and vincristine in normal and irradiated mice. J Natl Cancer Inst. 1968 Apr;40(4):847–854. [PubMed] [Google Scholar]
  25. Smyth J. F., Harrap K. R. Adenosine deaminase activity in leukaemia. Br J Cancer. 1975 May;31(5):544–549. doi: 10.1038/bjc.1975.95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Steel G. G., Courtenay V. D., Rostom A. Y. Improved immune-suppression techniques for the exongrafting of human tumours. Br J Cancer. 1978 Feb;37(2):224–230. doi: 10.1038/bjc.1978.30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Stein G. S., Stein J. L., Thomson J. A. Chromosomal proteins in transformed and neoplastic cells: a review. Cancer Res. 1978 May;38(5):1181–1201. [PubMed] [Google Scholar]
  28. Straw J. A., Talbot D. C., Taylor G. A., Harrap K. R. Some observations on the reversibility of methotrexate toxicity in normal proliferating tissues. J Natl Cancer Inst. 1977 Jan;58(1):91–97. doi: 10.1093/jnci/58.1.91. [DOI] [PubMed] [Google Scholar]
  29. THOMAS E. D., LOCHTE H. L., Jr, LU W. C., FERREBEE J. W. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N Engl J Med. 1957 Sep 12;257(11):491–496. doi: 10.1056/NEJM195709122571102. [DOI] [PubMed] [Google Scholar]
  30. Thomas E. D., Buckner C. D., Clift R. A., Fefer A., Johnson F. L., Neiman P. E., Sale G. E., Sanders J. E., Singer J. W., Shulman H. Marrow transplantation for acute nonlymphoblastic leukemia in first remission. N Engl J Med. 1979 Sep 13;301(11):597–599. doi: 10.1056/NEJM197909133011109. [DOI] [PubMed] [Google Scholar]
  31. UPHOFF D. E. Alteration of homograft reaction by A-methopterin in lethally irradiated mice treated with homologous marrow. Proc Soc Exp Biol Med. 1958 Dec;99(3):651–653. doi: 10.3181/00379727-99-24450. [DOI] [PubMed] [Google Scholar]
  32. Wilkinson R., Birbeck M. S., Harrap K. R. Enhancement of the nuclear reactivity of alkylating agents by prednisolone. Cancer Res. 1979 Oct;39(10):4256–4262. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES